| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8674630 | Nutrition, Metabolism and Cardiovascular Diseases | 2017 | 26 Pages |
Abstract
SGLT2-inhibitors are associated with an increase in the proportion of reports of ARF compared to other medications. SGLT2-inhibitor agents may differ from one another in their respective risk for ARF.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
A. Perlman, S.N. Heyman, I. Matok, J. Stokar, M. Muszkat, A. Szalat,